Navigation Links
Alexza and Grupo Ferrer Amend Adasuve™ Partnership
Date:3/7/2012

VE Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) in October 2011. 

For more information about Alexza, the Staccato system technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement
This press release contains forward-looking statements that involve significant risks and uncertainties. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs, including any future purchases of Alexza stock by Ferrer, the adequacy of the Company's capital to support the Company's operations, the Company having adequate authorized shares available to sell to Ferrer or for other uses, the Company's ability to raise additional funds and the potential terms of such potential financings, the potential of the Company's ADASUVE NDA resubmission to adequately address the issues in the Complete Response Letter, the timing of the FDA's review of the NDA, the eventual prospects that ADASUVE will be approved for marketing in the U.S., and the timing and prospects for regulatory approval to market ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2010, and the Company's other Periodic and Current Reports filed wit
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alexza Announces Proposed Public Offering of Common Stock and Warrants
2. FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexzas ADASUVE™
3. Alexza Presents Staccato® Loxapine Responder Analyses in Agitated Adult Patients with Schizophrenia or Bipolar Disease at the 2011 USPMHC Annual Conference
4. Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update
5. Alexza Pharmaceuticals to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
6. Alexza to Announce 2011 Third Quarter Financial Results on Monday, November 7, 2011
7. Alexza Announces the Adasuve™ (Staccato® Loxapine) PDAC Meeting Date of December 12, 2011
8. Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
9. Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America
10. Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
11. Alexza Announces Adasuve™ (Staccato® Loxapine) PDUFA Goal Date of February 4, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014  Today, ... a new extension to its PageCenterX ® ... software is designed to provide downtime reporting capabilities ... outages. LRS is releasing the product for general ... environment, EMR applications experience outages for a variety ...
(Date:7/31/2014)... 2014 Orexigen® Therapeutics, Inc. (Nasdaq: ... quarter 2014, on Thursday, August 7, 2014 before markets ... webcast and conference call at 8:00 a.m. Eastern time ... host the call and webcast to discuss financial results ... accessed by calling (800) 708-4540 (domestic) or (847) 619-6397 ...
(Date:7/31/2014)... SCOTTSDALE, Ariz. , July 31 2014  Northsight ... Bluher has been named Chairman and CEO of ... governance, risk management, legal matters, business development and investment ... in the securities industry.  Before his career on Wall ... Enforcement Division of the U.S, Securities and Exchange Commission ...
Breaking Medicine Technology:LRS Announces Downtime Reporting Solution for Healthcare 2Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Northsight Capital, Inc. Names Wall Street Veteran John Bluher, Former EVP And General Counsel Of Knight Trading Group, Chairman And CEO. 2
(Date:7/31/2014)... Alexandria, VA (PRWEB) July 31, 2014 ... Mesothelioma Applied Research Foundation, mesothelioma expert and executive ... APRN, stated that mesothelioma patients today have more promising ... In her talk, she mentioned several trials that have ... novel radiation treatments, while the focus of others is ...
(Date:7/31/2014)... Congress with bipartisan support would allow Medicare to test ... could improve the health of patients with chronic illness ... tests they need most. , The bill, introduced last ... grew out of a decade of work by health ... Policy and Innovation. It would allow Medicare Advantage plans ...
(Date:7/31/2014)... 31, 2014 Jacuzzi Luxury Bath, ... bathtub, has launched a new and improved website to ... , The Jacuzzi Luxury Bath website has been redesigned ... design and quality represented by the company’s products. The ... design and inspirational bathroom applications. “The site reflects our ...
(Date:7/31/2014)... at The Wistar Institute discovered that mice lacking ... age-related illnesses. The mice, which lack the TRAP-1 ... and spontaneous tumor formation when compared to normal ... the metabolic networks within cells. , In ... metabolism and has been shown to regulate energy ...
(Date:7/31/2014)... July 31, 2014 Global Markets ... provides an overview of the Brain Cancers therapeutic ... the therapeutic development for Brain Cancer, complete with ... drug target, mechanism of action (MoA), route of ... updates, and featured news and press releases. It ...
Breaking Medicine News(10 mins):Health News:‘More Promising Mesothelioma Clinical Trials than Ever Before,’ Says Expert 2Health News:‘More Promising Mesothelioma Clinical Trials than Ever Before,’ Says Expert 3Health News:Jacuzzi Luxury Bath Launches New and Improved Website 2Health News:'Rewired' mice show signs of longer lives with fewer age-related illnesses 2Health News:'Rewired' mice show signs of longer lives with fewer age-related illnesses 3Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 2Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 3Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 4
... October is National Physical Therapy,month and to ... Michigan residents to "Become a Physical Therapist or ... face uncertain economic times, the,physical therapy profession continues ... Director Aaron Bailey, PT, says there,is an urgent ...
... Oct. 30 Today URAC announced the,rollout ... technology,standards. The changes affect Health Web Site ... (Logo: http://www.newscom.com/cgi-bin/prnh/20030501/URACLOGO ), URAC, ... Privacy and Security standards to emphasize the ...
... International has named John T. Kelly, M.D., Ph.D. Chief Medical Officer. ... health and wellness of the users of Lifeclinic,s blood pressure monitors, ... ... MD (PRWEB) October 30, 2008 -- Lifeclinic International has ...
... CLEMSON Clemson University researchers developing imaging agents to ... received $180,000 from the Susan G. Komen Breast Cancer ... cancer deaths in American women. , The new method ... resonance imaging) that may help researchers look at different ...
... kick off American,Diabetes Month this November, the American ... Detroit, along with Eli,Lilly and Company,s national educational ... Diabetes Update, an educational program for people affected ... Saturday, November 1, at the Greater,Grace Temple, 23500 ...
... many hospitals have not,taken full advantage of opportunities ... see significant improvements in clinical,efficiencies, patient safety and ... Kermit Randa of Surgical Information Systems (SIS) and ... benefits realized through the,implementation of a best of ...
Cached Medicine News:Health News:The Physical Therapy Profession Remains in High Demand 2Health News:The Physical Therapy Profession Remains in High Demand 3Health News:URAC Rolls Out Revised Standards to Protect Personal Health Information and Boost Consumer Privacy on the Web 2Health News:Lifeclinic International Has Named John T. Kelly, M.D., Ph.D. Chief Medical Officer 2Health News:Susan G. Komen Breast Cancer Foundation awards grant for imaging-agent research 2Health News:American Diabetes Association and Eli Lilly and Company Unite to Educate and Empower African-Americans with Diabetes 2Health News:American Diabetes Association and Eli Lilly and Company Unite to Educate and Empower African-Americans with Diabetes 3Health News:Healthcare Providers Improve Financial, Clinical and Operational Efficiencies Through IT 2
... (TSH) is a 32 kDa glycoprotein secreted ... pituitary gland [1]. The structure of human ... pituitary and placental gonadotropins, consisting of an ... these hormones and a unique beta-subunit, which ...
... (T4) is the primary active hormone synthesized ... gland [1]. T4 is synthesized via a ... by the follicular cells, (ii) iodination of ... to formation of 3-monoiodotyrosine and 3,5-diiodotyrosine (MIT ...
... produced primarily by 5-monodeioination of thyroxine (T4) ... T3 production occurs at a rate which ... Release of T3 from the thyroid gland ... compared to 80-100 micrograms/day for T4. In ...
... protein-3 (IGFBP-3) is the main binding protein for ... component of the ~150 kDa ternary complex. This ... or IGF-II and ALS, allowing IGFBP-3, along with ... The molar concentration of IGFBP-3 in normal serum ...
Medicine Products: